Clinical Trials
DiaMedica completes enrollment in DM199 single ascending dose diabetes study
Clinical stage biopharmaceutical company DiaMedica has completed enrollment of type 2 diabetic patients in the DM199 single ascending dose (SAD) clinical study. ...
Drug Research
Supernus to launch Trokendi extended release formulation to treat epilepsy
Specialty pharmaceutical company Supernus Pharmaceuticals is set to launch once-daily extended release formulation of topiramate, Trokendi XR, to treat epilepsy following the final FDA...
IT & Data Management
HMS launches IntegritySource payment integrity suite for healthcare payers
HMS Holdings wholly owned subsidiary has launched HMS IntegritySource payment integrity suite for commercial and government healthcare payers. Aimed to...
News
FDA approves new drug to treat HIV infection
The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor...
Press Releases
Intellectual Property Protections Encourage More Drug Launches in the Cutting Edge Information
Research by Cutting Edge Information finds that intellectual property protections in the United States encourage more pharmaceutical drug launches relative to other countries with...
Press Releases
The International Myeloma Foundation Says Pomalidomide Approval in Europe Addresses Critical Need for More Treatment Options for Patients
The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today applauded...
News
Novartis first company accredited with global CEO Cancer Gold Standard
Novartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on Cancer, a group of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read